BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, July 15, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

Opening the Black Box that Leads to Black Box Warning

Oct. 17, 2012
By Anette Breindl
NEW ORLEANS – Lemming myths aside, suicide is one behavior that cannot be modeled in animal studies. But some of the risk factors that increase suicide risk in humans can.
Read More

Early Intervention Brings New Chances; New Questions, too

Oct. 16, 2012
By Anette Breindl
NEW ORLEANS – During her professional life, Barbara Sahakian told the audience on Monday at the 2012 annual meeting of the Society for Neuroscience, the approach to mental health problems has undergone a "shift from attempts to treat chronic relapsing mental health problems after they occur to an attempt to prevent them . . . or at least detect early and treat effectively."
Read More

Excited States of RNA Could Offer Targeting Possibilities

Oct. 15, 2012
By Anette Breindl
Understanding the structure of a biological molecule, whether it's a protein, DNA or RNA, is often critical for understanding its function.
Read More

GPCR Discoveries Honored with Chemistry Nobel Prize

Oct. 11, 2012
By Anette Breindl
On Wednesday, the 2012 Nobel Prize in Chemistry once again went for discoveries that would not have been surprising to see honored with Monday's Prize in Physiology or Medicine. It was awarded to Duke University's Robert Lefkowitz and Stanford University's Brian Kobilka "for studies of G-protein-coupled receptors."
Read More

Flu Vaccine Adjuvant Stretches Supplies, Hastens Immunity

Oct. 10, 2012
By Anette Breindl
From a public health perspective, the response to an influenza pandemic is a race against an emerging virus. And in that race, the virus has several advantages.
Read More

Yamanaka, Gurdon Share 2012 Nobel for Cell Reprogramming

Oct. 9, 2012
By Anette Breindl
Freshly minted Nobelist Shinya Yamanaka has a pretty humble explanation for his success: He wasn't any good as a surgeon.
Read More

Two-Day, $13K Sequencing IDs Genetic Diseases in the NICU

Oct. 5, 2012
By Anette Breindl

XBiotech's 'True Human' Antibody Xilonix Hits the Spot for Cachexia

Oct. 5, 2012
By Anette Breindl
Austin-based XBiotech Inc. is launching its first Phase III trial, for its antibody Xilonix (MABp1), after announcing Wednesday that the monoclonal antibody received fast-track designation by the FDA.
Read More

2-Day, $13K Sequencing IDs Genetic Diseases in the NICU

Oct. 4, 2012
By Anette Breindl
According to the March of Dimes charity, 10 percent to 15 percent of all newborns are admitted to the neonatal intensive care unit (NICU). Many of those babies suffer from genetic disorders. In fact, Stephen Kingsmore told reporters at a press conference, at his hospital – Children's Mercy Hospital in Kansas City – "the leading cause to admission to a neonatal intensive care unit is an illness that is likely to be genetic."
Read More

Scientists Present Grand Unified Theory of C-Myc

Oct. 2, 2012
By Anette Breindl
The transcription factor c-Myc is an oncoprotein; that much has long been clear. The c-myc gene is a known or suspected driver mutation in many cancer types.
Read More
Previous 1 2 … 236 237 238 239 240 241 242 243 244 … 403 404 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 14, 2026.
  • AI-generated  illustration of a neuron with tau protein aggregation

    AAIC 2026: Age of amyloid is being joined by time of tau

    BioWorld
    The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • NRF2 activators reported in Vailima Peninsula patent

    BioWorld Science
    Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 14, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing